[artículo] 
inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 6 (Diciembre) . - pp. 667-671

Título :	Association between the 1291-c/g polymorphism in the adrenergic α-2a receptor and the metabolic syndrome
Tipo de documento:	texto impreso
Autores:	Arne J. Risselada, Autor ; Jelle Vehof, Autor ; Richard Bruggeman, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 667-671
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	ADRA2A, Antipsicóticos, Síndrome metabólico, Esquizofrenia, 1291-C/G
Resumen:	The prevalence of the metabolic syndrome is increased in patients with schizophrenia compared with the general population. The strong interindividual differences in susceptibility to developing the metabolic syndrome suggests that the genetic makeup is a modulating factor. Part of the genetic puzzle can possibly be explained by variations in the gene coding for the adrenergic α-2a receptor (ADRA2A) because this receptor plays an important role in lipolysis.
Link:	./index.php?lvl=notice_display&id=29413

[artículo] Association between the 1291-c/g polymorphism in the adrenergic α-2a receptor and the metabolic syndrome [texto impreso] / Arne J. Risselada, Autor ; Jelle Vehof, Autor ; Richard Bruggeman, Autor . - 2022 . - pp. 667-671.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 6 (Diciembre) . - pp. 667-671

Palabras clave:	ADRA2A, Antipsicóticos, Síndrome metabólico, Esquizofrenia, 1291-C/G
Resumen:	The prevalence of the metabolic syndrome is increased in patients with schizophrenia compared with the general population. The strong interindividual differences in susceptibility to developing the metabolic syndrome suggests that the genetic makeup is a modulating factor. Part of the genetic puzzle can possibly be explained by variations in the gene coding for the adrenergic α-2a receptor (ADRA2A) because this receptor plays an important role in lipolysis.
Link:	./index.php?lvl=notice_display&id=29413